<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02569203</url>
  </required_header>
  <id_info>
    <org_study_id>BT_ICU_immune</org_study_id>
    <nct_id>NCT02569203</nct_id>
  </id_info>
  <brief_title>Effect of Immune-enhancing Enteral Nutrition on Immunomodulation in Critically Ill Patients</brief_title>
  <official_title>Effects of Enteral Formula Including Immune-modulating Nutrients on Clinical Course and Immune Function in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether high-protein (24% of total calorie from protein) enteral nutrition of
      immune modulating nutrients (eg, ω-3 fatty acids and antioxidants) enriched with β-glucan
      stimulates immune functions compared with standard enteral nutrition (control: 20% of total
      calorie from protein) or high-protein (24% of total calorie from protein) enteral nutrition
      of immune modulating nutrients without β-glucan in critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine whether high-protein (24% of total calorie from protein) enteral nutrition of
      immune modulating nutrients (eg, ω-3 fatty acids and antioxidants) enriched with β-glucan
      stimulates immune functions compared with standard enteral nutrition (control: 20% of total
      calorie from protein) or high-protein (24% of total calorie from protein) enteral nutrition
      of immune modulating nutrients without β-glucan in critically ill patients. In a randomized
      double-blind placebo-controlled study, 30 patients consumed 1 of 3 enteral nutrition:
      control, enteral nutrition of immune modulating nutrients enriched with β-glucan (250mg/L) or
      enteral nutrition of immune modulating nutrients without β-glucan. Enteral nutrition was
      initiated within 24 hours of ICU admission and continued during the ICU stay for a 7 days.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline NK cell activity at 7 days</measure>
    <time_frame>at baseline and 7 days follow-up</time_frame>
    <description>NK cell activity (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline IL-12 at 7 days</measure>
    <time_frame>at baseline and 7 days follow-up</time_frame>
    <description>IL-12 (pg/mL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline hs-CRP at 7 days</measure>
    <time_frame>at baseline and 7 days follow-up</time_frame>
    <description>hs-CRP (mg/dL)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>standard enteral nutrition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>test group I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high-protein enteral nutrition of immune modulating nutrients enriched with β-glucan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>test group II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high-protein enteral nutrition of immune modulating nutrients without β-glucan</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>standard enteral nutrition</intervention_name>
    <description>standard enteral nutrition</description>
    <arm_group_label>control group</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high-protein enteral nutrition of immune modulating nutrients enriched with β-glucan</intervention_name>
    <description>high-protein enteral nutrition of immune modulating nutrients enriched with β-glucan</description>
    <arm_group_label>test group I</arm_group_label>
    <other_name>test group I</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high-protein enteral nutrition of immune modulating nutrients without β-glucan</intervention_name>
    <description>high-protein enteral nutrition of immune modulating nutrients without β-glucan</description>
    <arm_group_label>test group II</arm_group_label>
    <other_name>test group II</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICU patients

        Exclusion Criteria:

          -  ICU patients who could not receiving enteral nutrition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Ho Lee, Ph. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Food and Nutrition, College of Human Ecology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-749, South Korea</affiliation>
  </overall_official>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2015</study_first_submitted>
  <study_first_submitted_qc>October 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2015</study_first_posted>
  <last_update_submitted>October 5, 2015</last_update_submitted>
  <last_update_submitted_qc>October 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

